{{Rsnum
|rsid=202676
|Gene=FOLH1
|Chromosome=11
|position=49206068
|Orientation=minus
|GMAF=0.3457
|Gene_s=FOLH1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 6.2 | 36.3 | 57.5
| HCB | 8.1 | 42.6 | 49.3
| JPT | 16.8 | 40.7 | 42.5
| YRI | 43.4 | 42.8 | 13.8
| ASW | 22.8 | 57.9 | 19.3
| CHB | 8.1 | 42.6 | 49.3
| CHD | 8.3 | 44.4 | 47.2
| GIH | 17.8 | 54.5 | 27.7
| LWK | 38.2 | 44.5 | 17.3
| MEX | 12.1 | 22.4 | 65.5
| MKK | 24.0 | 56.5 | 19.5
| TSI | 5.9 | 25.7 | 68.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=22124883
|Title=Glutamate carboxypeptidase II gene polymorphisms and neural tube defects in a high-risk Chinese population
}}

{{PMID Auto
|PMID=19048631
|Title=Oral facial clefts and gene polymorphisms in metabolism of folate/one-carbon and vitamin A: a pathway-wide association study.
|OA=1
}}

{{PMID Auto
|PMID=19706844
|Title=Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis.
}}

{{GET Evidence
|gene=FOLH1
|aa_change=Tyr60His
|aa_change_short=Y60H
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs202676
|n_genomes=1
|n_genomes_annotated=0
|n_haplomes=2
|n_articles=0
|n_articles_annotated=0
|nblosum100=-1
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=22021659
|Title=Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia.
|OA=1
}}

{{PMID Auto
|PMID=22918695
|Title=The maternal folate hydrolase gene polymorphism is associated with neural tube defects in a high-risk Chinese population.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}